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ABSTRACT
Objectives To assess the scope of the published 
literature on the consequences of maternal morbidity 
on health-related functioning at the global level and 
identify key substantive findings as well as research and 
methodological gaps.
Methods We searched for articles published between 
2005 and 2014 using Medline, Embase, Popline, CINAHL 
Plus and three regional bibliographic databases in January 
2015.
Design Systematic scoping review
Primary outcome Health-related functioning
Results After screening 17 706 studies, 136 articles 
were identified for inclusion. While a substantial number 
of papers have documented mostly negative effects 
of morbidity on health-related functioning and well-
being, the body of evidence is not spread evenly across 
conditions, domains or geographical regions. Over 60% 
of the studies focus on indirect conditions such as 
depression, diabetes and incontinence. Health-related 
functioning is often assessed by instruments designed 
for the general population including the 36-item Short 
Form or disease-specific tools. The functioning domains 
most frequently documented are physical and mental; 
studies that examined physical, mental, social, economic 
and specifically focused on marital, maternal and sexual 
functioning are rare. Only 16 studies were conducted in 
Africa.
Conclusions Many assessments have not been 
comprehensive and have paid little attention to important 
functioning domains for pregnant and postpartum 
women. The development of a comprehensive instrument 
specific to maternal health would greatly advance our 
understanding of burden of ill health associated with 
maternal morbidity and help set priorities. The lack of 
attention to consequences on functioning associated with 
the main direct obstetric complications is of particular 
concern.
Review registration CRD42015017774
IntroductIon
Maternal morbidity occurs frequently, but 
is poorly studied. At present, there are an 
estimated 27 million episodes of direct compli-
cations that occur annually.1 The burden of 
maternal morbidity is much larger than this 
estimate when indirect complications and 
long-term sequelae are added to the calcu-
lation, some of which can be particularly 
common.1 2 For example, anaemia affects 
32 million (a range of 28–36 million) preg-
nant women per year according to a model.3 
However, these estimates on the epidemi-
ology of maternal morbidity are based on 
varying criteria, which has prompted the 
establishment of the World Health Organi-
zation (WHO) Maternal Morbidity Working 
Group (MMWG) to develop a standard defi-
nition and measurement criteria.
By defining maternal morbidity as ‘any 
health condition attributed to and/or compli-
cating pregnancy and childbirth that has a 
negative impact on the woman’s wellbeing 
and/or functioning’4 the WHO MMWG 
emphasises the need for comprehensiveness 
in the evaluation of the maternal morbidity 
burden. Concurrently, global attention in 
policies such as the strategies toward Ending 
Preventable Maternal Mortality (EPMM) is 
shifting from focusing on maternal mortality, 
which is decreasing, to focusing on women 
who survive and addressing their morbidi-
ties.5 Indeed, while there is increased focus 
on describing the levels and patterns of 
maternal morbidity,1 6–8 the extent to which 
this morbidity collectively impacts upon 
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Research
Strengths and limitations of this study
 ► Extensive scoping review identifying key substantive 
findings and research and methodological gaps on 
the consequences of maternal morbidity on health-
related functioning at the global level. 
 ► The scoping review that includes a full range of 
maternal morbidities during pregnancy, childbirth, 
and postpartum, and assesses the impact on 
physical, mental, economic and social functioning.
 ► A quantitative meta-analysis could not be conducted 
given the wide range of conditions, tools, measures 
and timing of assessment of functioning.
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women’s health-related functioning is poorly under-
stood.9 10
Studies in the USA and Canada have demonstrated 
that pregnancy itself limits aspects of women’s func-
tioning.11 12 Changes in physical functioning from first to 
second trimesters, and from second to third trimesters 
have been observed among women with uncomplicated 
pregnancies.11 13–15 While acute complications soon disap-
pear after childbirth for most women, others may develop 
sequelae and experience certain health conditions, such 
as fatigue, sleep-related problems, pain, and concerns 
about sexual activities, depression, anxiety, haemorrhoids 
and constipation. These often last well over the 6 weeks 
of puerperium16 17 and have even been documented to 
peak around 6 months after delivery before declining.18 
Therefore, the additional effects of maternal morbidity 
on women’s functioning are important to comprehend, 
particularly with respect to differentials in patterns, dura-
tion, size and risk factors.4
The effects of maternal morbidity extend beyond the 
physical or the psychological to also social and economic. 
In Sri Lanka, 90% of pregnant women reported at least 
one episode of perceived ill health during pregnancy 
and 26% of them reported that they required another 
person to replace them in their routine activities because 
they were unwell.19 One hypothesis is that the more 
severe the maternal morbidity experienced the more 
likely the negative consequences. A handful of recent 
cohort studies have shown that women diagnosed with 
severe obstetric complications (including ‘near-miss’) 
had a higher risk of health, social and economic adver-
sities persisting well beyond pregnancy, and the 6-week 
postpartum period compared with women with uncom-
plicated childbirth.20–28
The most comprehensive source of summarised 
evidence to date on the consequences of maternal 
morbidity is a systematic review on health-related quality 
of life (HRQOL) after childbirth.29 This review of 66 
articles concentrated on the physical, social and psycho-
logical domains. While it did not focus specifically on 
the effects of maternal morbidity, the authors found that 
urinary incontinence and HIV were negatively correlated 
with quality of life (QOL), and that depression had an 
impact on health status scores such as those measured 
by the 36-item Short Form (SF-36).29 More recently, 
Andreucci et al reviewed the effects of maternal morbidity 
on sexual dysfunction. Despite the substantial meth-
odological heterogeneity between studies, they found 
an association between perineal injuries with increased 
dyspareunia and delayed resumption of sex after child-
birth.30 In contrast, a recent cohort study shows sexual 
function 3 months after delivery, for women who had 
severe maternal morbidity, was similar to the level of the 
control group.31 The effects of other maternal morbidities 
on health-related functioning and QOL have rarely been 
investigated in systematic reviews.29 Additionally, studies 
such as those mentioned above focus on the impact of a 
morbidity with a limited anatomical interpretation (ie, a 
perineal injury’s impact on a woman’s sexual life), rather 
than a more holistic view on how women’s everyday abil-
ities may be impacted (eg, her overall relationship with 
her partner, not limited to sex, or her ability to care for 
the child or resume her economic activity).
concepts and measurement of health-related functioning 
and QoL/well-being
The difference between health-related functioning 
and HRQOL may be ambiguous, as there is overlap. 
Functioning and disability (the negative correlate of 
functioning) are conceptualised by the International 
Classification of Functioning, Disability and Health 
(ICF). The ICF classified functioning and disability 
into three levels: at the level of body or body part, the 
whole person, and the whole person in a social context. 
Disability is defined as ‘the outcome of the interaction 
between a person with an impairment and the environ-
mental and attitudinal barriers he or she may face.’32 
The concept of disability is not restricted to impairment 
of body function and structures. It encompasses loss or 
limited capacity to execute a task or action by individual 
(eg, eating, standing, walking), and to be involved in a 
life situation in an environment (eg, employment). The 
ICF is also the international classification and metrics for 
organising and reporting health and disability data which 
enables us to use common metrics over time and space.
QOL and the more specific notion of HRQOL are 
also widely used to understand how diseases or the 
absence of disease influences the lives of individuals. It 
relates to the broader concept of well-being than the 
concept of health-related functioning, and encompasses 
perception of life satisfaction which is shaped by many 
factors including health.33 Although there are many 
definitions, QOL has been defined by WHO as the 
‘individual’s perception of their position in life in the 
context of the culture and value systems in which they 
live and in relation to their goals, expectations, stan-
dards and concerns.’33 As explicitly stated in the WHO’s 
definition, QOL gives weight to individual’s perception 
of the ability to lead a fulfilling life.34 The concept of 
HRQOL encompasses aspects of QOL which can clearly 
affect health or be affected by health conditions, and is 
defined as ‘optimum levels of mental, physical role and 
social functioning, including relationships and percep-
tions of health, fitness, life satisfaction and wellbeing.’35 
In contrast, health-related functioning does not focus on 
individual’s perception or subjective well-being. It can 
be based on established comparable parameters such as 
the ICF, and provide more precise information on level 
of functioning than HRQOL.36 Effective healthcare plan-
ning and management needs comparable data on level of 
functioning, which predict work performance, return to 
work potential, likelihood of social integration or receipt 
of disability benefits.32
Health-related functioning and HRQOL are important 
patient-reported health outcomes which have been 
used in other sectors of public health to measure the 
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effectiveness of intervention or to allocate resources.37 
However, most of the existing studies of maternal health 
focus on mortality and morbidity, and there is limited 
research that aims to assess women's QOL as a primary 
outcome.38 The guidelines on postnatal care up to 8 weeks 
after birth developed by the British National Institute for 
Health and Care Excellence recommend health profes-
sionals to check women’s physical, emotional and social 
well-being.39 More complete data on maternal morbidities 
and consequences would contribute to setting priorities 
for reducing the burden of maternal ill health.
Nonetheless, measurement of health-related func-
tioning and QOL is complex. While these concepts are 
concerned with individual’s perceptions of personal 
health, well-being and satisfaction with health status 
and life, predetermined quantitative scales are often 
applied. There are a number of standardised generic 
instruments used to measure functioning and QOL. 
For instance, the SF-36 is one of the most commonly 
used tools for assessing functioning and well-being, and 
often employed to assess the performance of new instru-
ments. The SF-36 has been validated among women in 
early pregnancy.40 However, women during late preg-
nancy or postpartum were not taken into account during 
the instrument development process, and indeed, no 
generic tools assessed their reliability, validity or respon-
siveness for these specific populations in different 
settings.41 Tools developed specifically for use in relation 
to maternal health include the Inventory of Functional 
Status After Childbirth (IFSAC), which focuses on social 
functioning,42 the Mother Generated Index, which is 
self-created by each individual woman to assess the effect 
of having a new baby on her QOL,43 and the Maternal 
Postpartum Quality of Life tool (MAPP-QOL) with 
emphasis on women’s satisfaction with various areas of 
their life during early postpartum.44 All of these tools are 
concerned with events in the postpartum period in rela-
tion to the experience of childbirth, were validated in 
relatively homogenous and small study populations and 
have been applied infrequently.41
As members of the MMWG, we conducted a systematic 
scoping review of the published literature on the short-
term and long-term consequences of maternal morbidity 
on health-related functioning to assess the scope of the 
literature at the global level, identify key substantive find-
ings as well as research and methodological gaps.45 In 
this paper, we critically appraise the available literature 
with particular interest in the type of conditions studied, 
the tools used, the range of domains considered, the 
timing of assessment, the study design and geograph-
ical coverage. We then qualitatively assess the range of 
domains studied and the effects of morbidity. Finally, we 
focus on two conditions, hyperemesis gravidarum and 
incontinence during pregnancy to illustrate characteris-
tics of included studies and the impacts on health-related 
functioning.
Methods
data sources and search strategy
We adapted a WHO generic protocol used in all the 
systematic reviews conducted by members of the 
MMWG.10 46 The protocol is registered in PROSPERO 
(CRD42015017774, http://www. crd. york. ac. uk/ PROS-
PERO/ display_ record. asp? ID= CRD42015017774). We 
searched relevant articles published between 1 January 
2005 and 31 December 2014 using a structured search 
strategy in four bibliographic electronic databases 
(Medline, Embase, Popline, CINAHL Plus) and three 
WHO regional databases (Latin American and Caribbean 
Center on Health Sciences Information, African Index 
Medicus and the West Pacific Region Index Medicus) in 
January 2015. We focused on the literature published in 
2005 or later given the size of literature and because we 
expect to have more papers relevant to our aim in recent 
years in view of the fact that the ICF that provides a 
comprehensive framework of health-related functioning 
was introduced by WHO only in 2002.
A full search strategy for each database was developed 
using thesaurus (including MeSH) and free-text terms 
for maternal morbidity and health-related functioning. 
We added search terms relating to individual maternal 
health conditions based on the maternal morbidity 
matrix constructed by Chou et al.4 The outcome for this 
review, health-related functioning, encompasses multiple 
dimensions, such as cognitive, physical, mental, social 
and economic functions, and the terms relating to each 
of these concepts were included in the search strategy. 
While the primary focus of the systematic scoping review 
is the negative impact of morbidity on health-related func-
tioning, HRQOL findings (and other concepts capturing 
the consequences of morbidity) were added to make sure 
that we captured all of the relevant literature. This is also 
because the WHO maternal morbidity definition includes 
both the terms ‘wellbeing’ and ‘functioning’. The search 
strategy is available in online supplementary appendix 1.
Inclusion and exclusion criteria
All studies were eligible for inclusion if they met the 
following criteria: (1) the study population included at 
least 30 women who experienced maternal morbidity 
during pregnancy, childbirth or 1 year after delivery or 
spontaneous abortion; and (2) results included quan-
titative data on health-related functioning by maternal 
morbidity status. Thus, we included any studies which 
assessed outcome, that is, health-related functioning, at 
any time after delivery because we aimed to examine 
long-term as well as short-term consequences of 
maternal morbidities. We excluded intervention studies 
if respondents were all treated and the primary objec-
tive of the study was comparisons of treatment. Studies 
with no primary data were excluded. All other study 
types were eligible. There were no language restrictions.
Induced abortion, stillbirth and preterm birth were 
excluded from this review when they were the only expo-
sure in a study. While these outcomes may be associated 
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Figure 1 Study selection for inclusion in the systematic scoping review.
AIM, African Index Medicus; WPRIM, West Pacific Region Index Medicus.
with maternal complications, they are not exclusively 
maternal morbidities. Intimate partner violence, 
substance use, smoking, alcohol, female genital mutila-
tion and multiple pregnancies were also not considered 
maternal morbidities for the purposes of this review, 
though these factors increase the risk of maternal 
morbidities. A number of studies assessed depression 
or depressive symptoms as consequences of maternal 
morbidities using screening tools such as the Edinburgh 
Postnatal Depression Scale or the 9-item Patient Health 
Questionnaire. Although individual questionnaire items 
in some of these tools imply women with the condition 
have low level of functioning, we excluded studies that 
did not explicitly report on mental functioning as an 
outcome as it was not possible to separate characteris-
tics and severity of depressive symptoms, and level of 
functioning. Studies that assessed any of the following: 
practice of breastfeeding, self-efficacy, locus of control, 
confidence, competence, self-esteem, life satisfaction 
and social support, as an outcome but did not assess 
this in the context of women’s health-related func-
tioning were not included. Although maternal–infant 
interaction was sometimes chosen as an outcome in 
studies on depression, this review excluded studies if 
they did not explicitly examine woman’s ability to care 
for her child as functioning.
selection and data extraction
Four authors (KM, AH, JAC, VF) with help from a 
research assistant (LP) screened titles and abstracts. At 
the beginning of the screening, a pilot test of 100 papers 
by three reviewers (KM, AH, JAC) was conducted to 
help achieve inter-rater reliability. Evaluation of full-text 
reports was done by four authors (KM, AH, JAC, VF), 
with reasons for exclusion recorded for excluded papers. 
Data extraction from the full-text report was conducted 
by a single author for each retained paper (KM, AH, 
JAC, VF, MB, DC); information was extracted on: loca-
tion of study, study dates, study design, study population, 
sampling, case definition of maternal morbidity, methods 
of measurement of health-related functioning and the 
timing of the assessment, and measures of functioning by 
morbidity status. When a study assessed multiple maternal 
morbidities or examined health-related function several 
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Table 1 Description of included studies
Direct 
morbidity 
(n=52) (%)
Indirect 
morbidity 
(n=84) (%)
Total 
(n=136) 
(%)
Region
  Africa 5.8 15.5 11.8
  Asia 15.4 20.2 18.4
  Europe 48.1 26.2 34.6
  Latin America and 
the Caribbean
3.8 6.0 5.1
  North America 13.5 26.2 21.3
  Oceania 7.7 3.6 5.1
  Multiple 5.8 2.4 3.7
Timing of assessment of functioning
  Antepartum 19.2 27.4 24.3
  Antepartum and 
postpartum
11.5 7.1 8.8
  Postpartum (≤1 year) 26.9 42.9 36.8
  Postpartum (>1 year) 23.1 6.0 12.5
  Postpartum (both 
≤1 year and >1 year)
7.7 11.9 10.3
  Postpartum 
(unknown)
1.9 2.4 2.2
  Not specified 9.6 2.4 5.1
Study design
  Cohort 63.5 40.5 49.3
  Cross sectional 23.1 41.7 34.6
  Trial 7.7 15.5 12.5
  Case–control 5.8 2.4 3.7
Comparison (control) group relevant to maternal 
morbidity and functioning
  Yes 61.5 48.8 53.7
  No 38.5 51.2 46.3
Total 100 100 100
times, data of functioning for each health condition 
and at each time point of observation were extracted. 
Throughout the reviewing and extraction processes, 
articles where uncertainty existed were discussed with 
another reviewer and consensuses reached. Finally, as it 
is not possible to summarise the results statistically across 
studies by morbidity because of their differences with 
respect to research questions, study designs, outcome 
measures, timing of measurement and control group, 
two authors (KM, VF) qualitatively assessed each paper to 
determine the impact of the morbidity on five domains: 
physical, mental, economic, social and other (see online 
supplementary appendix 2). If there had been a set 
of articles that used a given tool to assess impacts of a 
clearly defined maternal health condition on a well-de-
fined functioning (or dimension(s) of functioning) at a 
given period among women with similar characteristics, 
we could have combined the quantitative results and 
conduct a meta-analysis. Self-reported general health 
status, maternal, sexual or marital functioning were cate-
gorised as ‘other’ domain. The economic domain was 
interpreted broadly and included ability to conduct both 
paid and unpaid work. We relied on authors’ interpre-
tations of their study findings when the studies did not 
have a control or comparison group, or did not provide 
a statistical test comparing women’s functioning between 
morbid and non-morbid groups. Appraisal of the quality 
of studies was conducted based on definition of maternal 
morbidity and health-related functioning, inclusion of 
relevant controls, sampling methods and completeness of 
data. Despite a high proportion of poor quality of studies 
for the purpose of the study, we included all publications 
relevant to our study aim in this scoping review.
resuLts
Our initial database search identified 17 706 relevant 
studies. After screening of titles and abstracts, 382 papers 
were retained. Of those, we excluded a total of 246 arti-
cles after full-text review and data extraction. The main 
reason for exclusion was lack of well-defined maternal 
morbidity or health functioning data. Finally, 136 papers 
were identified for inclusion (figure 1).
Using the classification of maternal morbidity 
constructed by Chou et al,4 the vast majority of the 
included articles, 84 articles out of 136 (62%), addressed 
the consequences of indirect causes of morbidity on 
health-related functioning (see table 1). The studies 
were concentrated in Europe and North America (56%, 
76 studies), and only 12% (16 studies) were located in 
Africa. Health-related functioning in the immediate or 
extended postpartum period, especially within 1 year of 
delivery, was more commonly studied, compared with 
the antepartum period. Cohort study was a particularly 
common study design. Almost half of the included papers 
(46%, 63 studies) did not have a control group.
Table 2 presents distributions of 140 maternal health 
conditions which were studied as exposures in the 136 
included articles. The three most frequent maternal 
morbidity diagnoses studied were mental disorders (33%, 
45 studies), incontinence (12%, 17 studies) and perineal 
laceration (9%, 13 studies). Hyperemesis gravidarum, 
and nausea and vomiting of pregnancy were studied in 
nine studies (6%). The consequences on health-related 
functioning of potentially more severe direct obstetric 
conditions, such as obstetric haemorrhage or severe 
pre-eclampsia and eclampsia, were not frequently studied. 
There are limited data on the consequences of puerperal 
sepsis on health-related functioning except in three near-
miss studies.
Health-related functioning and well-being were 
measured by applying a number of existing tools (table 3). 
The SF-36 was the most common tool applied and used in 
32 studies (22%). It was particularly common in studies of 
gestational diabetes and mental disorders. The Short Form 
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Table 2 Distribution of maternal conditions
Delivery/termination (n=7) Number of conditions Percent
Direct maternal morbidity
  Gestational trophoblastic disease 6 4.3
  Obstructed labour 1 0.7
Hypertensive disorders (n=7)
  Gestational hypertension 2 1.4
  Pre-eclampsia/eclampsia 5 3.6
Obstetric haemorrhage (n=3)
  Postpartum haemorrhage 3 2.1
Other obstetric complications (n=23)
  Gastrointestinal (n=9)
   Nausea and vomiting of pregnancy 3 2.1
   Hyperemesis gravidarum 6 4.3
  Endocrine (n=8)
   Diabetes mellitus (gestational diabetes) 8 5.7
  Others (n=6)
   Deep vein thrombosis 1 0.7
   Near-miss* 3 2.1
   Multiple obstetric conditions 2 1.4
Unanticipated complications (n=14)
   Perineal laceration 13 9.3
   Spontaneous abortion 1 0.7
Indirect maternal morbidity
  Anaemia 3 2.1
Endocrine, nutritional and metabolic diseases (n=2)
  Type 1 diabetes 1 0.7
  Cystic fibrosis 1 0.7
Infection (n=5)
  HIV infection 5 3.6
Mental disorders (n=45)
  Depression 42 30.0
  Obsessive compulsive disorder 1 0.7
  Multiple 2 1.4
Diseases of the respiratory system complicating pregnancy, childbirth and the puerperium (n=1)
  Bronchial asthma 1 0.7
Diseases of the genitourinary system (n=24)
  Urinary/faecal/anal incontinence 17 12.1
  Fistula 7 5.0
Diseases of the nervous system (n=2)
  Multiple sclerosis 2 1.4
Diseases of the circulatory system (n=1)
  Heart disease 1 0.7
Diseases of the digestive system (n=3)
  Enteritis and colitis 1 0.7
  Gastro-oesophageal reflux disease 1 0.7
  Functional intestinal disorders 1 0.7
Total 140 100.0
*Includes an indirect cause, severe anaemia.
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Table 3 Distribution of maternal conditions by type of tools used in the included studies to measure well-being and 
functioning
Health-functioning tool
SF-36 SF-12
WHOQOL-
BREF
WHODAS 
2.0
Disease 
specific Own tool Others Total
Direct maternal morbidity
  Delivery/termination 0 1 1 0 1 2 2 7
  Hypertensive disorders 3 1 1 0 1 1 0 7
  Obstetric haemorrhage 2 0 0 0 0 1 0 3
  Other obstetric 
complications
7 0 2 0 4 6 5 24
  Unanticipated 
complications
3 1 0 0 6 2 4 16
Indirect maternal morbidity
  Maternal infectious and 
parasitic diseases
1 0 1 0 0 2 1 5
  Mental disorders 11 4 2 2 0 1 27 47
  Diseases of the 
genitourinary system
1 0 1 0 13 8 3 26
  Other indirect courses 4 0 0 0 6 0 3 13
Total 32 7 8 2 31 23 45 148
Note: 12 studies used more than one type of tool.
SF-12, Short Form 12; SF-36, 36-item Short Form; WHODAS 2.0, WHO Disability Assessment Scale 2.0; WHOQOL-BREF, WHO Quality of 
Life tool.
12, the WHO Quality of Life tool (WHOQOL-BREF) and 
WHO Disability Assessment Scale (WHODAS) 2.0 were 
used in fewer than 10 studies each. Over 30 studies used 
disease-specific tools. Seventeen studies on incontinence 
were documented, and the International Consultation on 
Incontinence Questionnaire Urinary Incontinence Short 
Form (ICIQ-UI-SF), the Incontinence Impact Question-
naire (IIQ-7), the Faecal Incontinence Quality of Life 
(FIQL) Score, and the King’s Health Questionnaire 
and Manchester Health Questionnaire were commonly 
used. While these existing tools were often adopted, 
many studies applied other tools, especially in studies 
on mental disorders, including Female Sexual Function 
Index (six studies), Global Assessment of Functioning 
(four studies), Perceived Stress Scale (two studies) and 
Pittsburgh Sleep Quality Index (two studies).
A list of the included articles and the impact of the 
morbidity on five domains of functioning: physical, 
mental, economic, social and other, which we assessed 
for each article, is in online supplementary appendix 2. 
Among the 136 papers, 116 studies reported negative 
consequences of maternal morbidity; only 20 articles 
found no negative impact. There is no maternal health 
condition for which studies consistently showed no impact 
on health-related functioning. Physical and mental 
functioning was frequently assessed, and economic func-
tion was rarely studied. Studies of fistulae were often 
concerned with social, marital and economic domains, 
and perineal laceration studies often documented sexual 
functioning. Lastly, environmental factors (facilitators and 
barriers) of women’s functioning were rarely reported in 
the included papers except for a handful of papers such 
as those addressing fistulae47–51 and near-miss.23 Panel 1 
and 2 illustrate characteristics of studies of hyperemesis 
gravidarum and incontinence during pregnancy and the 
impacts on health-related functioning.
Panel 1: hypermesis gravidarum
Hyperemesis gravidarum, a severe and persistent form of 
nausea and vomiting in pregnancy, affects up to 1.5% of 
pregnant women, with an onset at about the fifth week of 
pregnancy, peaking at 8–12 weeks and usually resolving 
before the 20th week.52 Only five studies examined 
health-related functioning as a consequence of hyperem-
esis gravidarum during pregnancy. They were all conducted 
in high-income countries except for one conducted in 
Turkey. Existing generic tools were used in three of these 
studies (Perceived Stress Scale (PSS), Brief Disability Ques-
tionnaire and Social Functioning Questionnaire (SFQ)). 
A disease-specific tool, Hyperemesis Impact Symptoms 
Questionnaire, was used in one study; and one study did 
not use any existing tool and researchers created their own 
items. Despite the different tools used, there was evidence 
of a significant impact of morbidity on women’s daily lives 
in four studies while one study reported no impact. In a 
prospective cohort study of pregnant women with and 
without hyperemesis gravidarum, McCarthy et al applied 
the PSS and a Behavioural Response to Pregnancy Scale 
comprising two subscales: limiting/resting behaviour 
(referring to a tendency to curtail activities of daily living 
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in response to symptoms by resting).53 Limiting/resting 
response and PSS scores were higher in women with hyper-
emesis gravidarum than women without hyperemesis 
gravidarum after adjusting for possible confounders, such 
as age, smoking and ethnicity. As the limiting behaviour 
score normalised several weeks after vomiting ceased, 
a causal association between hyperemesis gravidarum 
and deteriorated functioning was suggested in this study. 
Ezberci et al used the 11-item Brief Disability Questionnaire 
to assess physical and social disability and showed that the 
score was higher in women with hyperemesis gravidarum 
than women without (11.2 vs 8.5).54 Power et al developed 
and validated the 10-item Hyperemesis Impact of Symptom 
(HIS) questionnaire to assess how symptoms of hyper-
emesis gravidarum were impacting women’s lives.55 The 
authors showed a significantly higher mean HIS score in 
women with hyperemesis gravidarum than those without it 
(16.3 vs 5.6). On the other hand, McCormack et al56 used 
a short 8-item Social Functioning Questionnaire to assess 
social functioning in different situations (such as at home, 
work or in relationships) and showed no difference in the 
Social Functioning Questionnaire scores between women 
with and without hyperemesis gravidarum, both at around 
the peak of symptoms and after 26th week when vomiting 
had ceased.56 It was unclear whether the small sample size 
(32 with hyperemesis gravidarum and 41 without hyperem-
esis gravidarum) or difference in gestational weeks among 
the women (hyperemesis gravidarum: 9.66 weeks (95% CI 
8.69 to 10.63), non-hyperemesis gravidarum: 12.27 weeks 
(95% CI 11.71 to 12.83)) might have been responsible for 
the lack of association between hyperemesis gravidarum 
and impaired social functioning, or whether hyperemesis 
gravidarum may not have impacted the women’s daily func-
tioning. Poursharif et al57 presented the type of problems 
women reported to have experienced as a consequence 
of hyperemesis gravidarum in a spontaneous response to 
the question ‘how have your life or future plans changed 
after experiencing hyperemesis?’ These included prob-
lems with job or school, marital or family relationships and 
social isolation.57 However, while the paper documented 
the negative psychological and social impacts of hyperem-
esis gravidarum, the study had important limitations. It did 
not specifically focus on health-related functioning nor did 
it use a comprehensive conceptual framework, the online 
recruitment survey relied on self-referral and self-diagnosis 
of hyperemesis gravidarum, the duration (since hyperem-
esis gravidarum onset was not explored) and there was no 
comparison group.
Hyperemesis gravidarum is an example of a condition 
for which there is no dominant condition-specific tool. 
While three studies used generic tools and one study 
used only its own questions, the condition-specific tool 
developed by Power et al appears to capture well how 
hyperemesis gravidarum-associated morbidity impacts key 
aspects of women’s daily life. However, other domains of 
health-related functioning considered in the review (eg, 
sexual functioning) were not part of the condition-specific 
tool.
Panel 2: Faecal and urinary incontinence during pregnancy
Incontinence is an example of a condition for which 
there are existing health-related functioning or QOL 
tools, developed in the 1990s, and sometimes applied in 
pregnant and postpartum populations. Faecal or urinary 
incontinence, that is, involuntary leakage of stool or 
urine, is a common antenatal condition from which up 
to 60% of women suffer during pregnancy.58 59 Anatom-
ical changes such as enlargement of the uterus putting 
increased pressure on the bladder are responsible. Five 
studies examined the association between urinary incon-
tinence and health-related functioning during pregnancy, 
one examined the association with faecal incontinence 
and another assessed both faecal and urinary inconti-
nence. Three were conducted in high-income countries 
and four in middle-income countries. Three studies 
used the ICIQ-UI-SF, which comprised three questions 
relating to severity of urinary incontinence and one ques-
tion regarding impact on daily life. However, the studies 
differ with respect to the research question, study designs, 
outcome measures and control group.
In a Brazilian study, the mean composite ICIQ score 
was just above 12. There is no cut-off in the ICIQ score, 
but a mean score of 12 is considered as severe impact 
on QOL.60 A Nigerian cross-sectional study, which used 
ICIQ-UI-SF, reported that in 17% of women, urinary 
incontinence interfered with daily life. The mean score 
of ICIQ-UI-SF among 43 women in this study was much 
lower than in the Brazilian study (4.05).61 In a cohort 
study conducted in Spain, the impact of urinary incon-
tinence was measured using the ICIQ-UI-SF and the 
percentage of women reporting an impact on daily 
life was high in each trimester with an upward trend as 
pregnancies progressed. Similar results were reported 
in women with double (urinary and anal) incontinence 
in this study. Another study in Spain, which used IIQ-7, 
reported no impact on daily life.62 The 28-item, condi-
tion-specific Wagner’s Quality of Life Scale was used in 
a cross-sectional study from Turkey and 71% of women 
with urinary incontinence reported that it had an impact 
on their QOL.63 Erbil et al developed a 23-item question-
naire based on existing literature to explore the aspects 
of daily life affected by urinary incontinence in Turkey.58 
The study found that a large proportion of women were 
affected by urinary incontinence in some areas of their 
lives. Particularly affected were: daily activities (75%), 
feeling of discomfort (73%), liquid avoidance (53%), 
sexual life (47%) and isolation from environment (36%). 
Johannessen et al studied faecal incontinence during 
pregnancy and used the 29-item FIQL which has four 
subscales.64 One quarter of the women in Norway reported 
that faecal incontinence in late pregnancy affected their 
behaviour and increased embarrassment. These studies 
suggest that women’s daily lives were negatively affected 
by incontinence to a great extent. However, because of 
the use of condition-specific tools in assessing health-re-
lated functioning and hence the lack of a comparison 
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group, functioning of healthy counterparts was not used 
as a benchmark in the majority of these studies.
dIscussIon
While a substantial number of studies (n=116) have 
documented mostly negative effects of morbidity on 
health-related functioning and well-being during preg-
nancy and after childbirth, the body of evidence is not 
spread evenly among conditions, domains of health-re-
lated functioning or geographically. Most studies focus 
on indirect conditions such as depression, diabetes and 
incontinence. The effects of direct obstetric complica-
tions, including haemorrhage and pre-eclampsia, have 
rarely been studied, except for obstetric fistulae linked 
to obstructed labour, despite their importance in low-in-
come and middle-income countries. The functioning 
domains studied were also limited, most frequently 
documenting physical and mental categories; studies of 
fistulae were often concerned with social, marital and 
economic domains; and perineal laceration studies often 
documented sexual functioning. Studies that compre-
hensively documented all domains, including physical, 
mental, social, economic, and specifically focused on 
marital, maternal and sexual limitations, were rare and 
used their own tools instead of tools previously validated 
by others. This overall narrow focus on the women’s 
perspective highlights the need for a tool to address the 
women’s health-related functioning more holistically. 
Furthermore, most of the instruments reviewed have no 
link with a common data standard such as ICF. This is 
another reason why the data gathered from the instru-
ments are in data silos, and it is impossible to compare and 
aggregate data across the studies. Finally, the number of 
studies, conducted in Africa region, where the morbidity 
disability-adjusted life years are the highest, is small, with 
only 16 studies. These mostly concentrated on the effects 
of fistulae, depression and near-miss complications.
The geographical imbalance in our findings may be due 
to research in low-income and middle-income countries 
putting greater emphasis on reducing maternal mortality, 
which has been a central focus of the Millennium Devel-
opment Goals (MDGs).65 Greater localised interest in 
mental health and other chronic conditions which affect 
women over many years, including into menopause, is 
another reason for the concentration of studies in high-in-
come countries. The proportion of studies on depression 
is also related to its high prevalence among postpartum 
women (prevalence from 13% to 19%),8 specialised 
interest by psychiatrists and psychologists, and concerns 
over its impact on child development.66 Urinary inconti-
nence is a very prevalent condition (estimated prevalence 
of stress urinary incontinence at 41%, ranging from 19% 
to 60%67) and widely studied. As shown in the current 
review, urinary incontinence has been found to have 
negative impact on physical and psychological QOL, but 
also socioeconomical and sexual well-being of women’s 
lives.
A high proportion of papers were found to be of poor 
quality for the purpose of this review, as many (46%) 
did not have an appropriate control group. The lack of 
adequate comparison group (such as women without the 
morbidity of interest, women with uncomplicated child-
birth or at the very least women of reproductive age) 
is problematic when assessing the effects of maternal 
morbidity. Several cohort studies attempted to circum-
vent this problem by using the normative findings for 
their chosen tools available for the general population. 
However, this is not fully appropriate as pregnant women 
and women with small babies may be different from the 
general population and have special circumstances, such 
as those related to physically carrying a pregnancy and 
breast feeding their small babies. They may also experi-
ence cultural limitations including their ability to leave 
home and perform the ‘normal’ activities of healthy adults 
such as paid and unpaid work. Use of normative findings 
could also lead to an underestimation of the impact of 
maternal morbidity, as women who become pregnant 
are mostly very healthy.68 It is these differences from the 
general population that need further research and a tool 
based on standardised concepts to provide better, more 
scientifically sound comparisons among pregnant and 
postpartum women.
As found in the other systematic review of health-re-
lated functioning,29 the majority of papers used SF-36. 
WHOQOL-BREF is also applied to capture QOL. SF-36 
is widely used, in view of its longevity (it was created in 
1992), its availability (having been translated for use in 
more than 40 countries) and the accumulated evidence 
on its psychometric properties for different popula-
tions. It allows researchers to compare the impact of a 
range of diagnoses and conditions, not just obstetric and 
gynaecological conditions. It is also comprehensive, as it 
documents general health, physical functioning, mental 
health, bodily pain, vitality, role limitations because of 
physical and emotional problems, and social functioning. 
Several maternal morbidity studies that used SF-36 and 
WHODAS 2.0 showed a correlation with morbidity, indi-
cating that they have discriminant or predictive validity. 
Similar correlation was observed with condition-specific 
tools such as those available for incontinence. However, 
these generic and condition-specific tools have not 
been validated among pregnant or postpartum women 
in different settings. They also do not include maternal 
functioning, and they do not provide sufficient emphasis 
on economic, marital and sexual functioning which 
are important domains for women of reproductive age. 
Several reviewed studies assessed the consequences of 
maternal morbidity on the ability to breastfeed and 
respond to the baby’s needs, although they did not assess 
them in the context of women’s functioning.69 70 This is a 
particularly important aspect of maternal functioning to 
investigate.
Therefore, we believe that a health-related functioning 
tool specific to maternal health should be developed to 
measure the impact of additional maternal morbidity 
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or pregnancy. The tool would contribute to addressing 
the evidence gap in our knowledge on consequences 
of maternal morbidity on woman’s daily life, and will 
advocate for the importance in improving the health of 
women during pregnancy, childbirth and postpartum. 
The three currently available tools for postpartum 
populations discussed earlier have limitations as they 
are either QOL tools with an emphasis on satisfaction 
or feeling (MAPP-QOL and Mother Generated Index) 
or have too narrow in scope (IFSAC). The MAPP-QOL 
tool includes the majority of relevant domains including 
physical, psychological, social, marital, sexual, economic 
and maternal functioning, but its focus on satisfaction 
and areas such as physical appearance and environment 
makes it unsuitable for measurement of health-related 
functioning. Ideally, a health-related functioning tool 
specific to maternal health would be comprehensive 
(physical, mental, social, economic, marital, sexual and 
maternal functioning) and should be applicable to condi-
tions that occur during both pregnancy and postpartum 
periods and comparable across different populations. A 
new tool specific to maternal health needs to link existing 
and new functional status measurement instruments to 
a common data standard and the conceptual framework 
of the ICF to enable us to compare health-related func-
tioning data across studies.
Inclusion of environmental factors (facilitators 
and barriers) of women’s functioning should also be 
accounted for in the development of a new instrument 
specific to maternal health. As noted earlier, disability 
is the outcome of the interaction with a person with a 
impairment and the environment.32 Level of functioning 
varies by environmental factors, such as health services, 
support and attitudes from family members and commu-
nities.71 Interventions that address women’s impairment 
and personal factors and modify the environment in 
which women with maternal morbidities live could 
improve women’s health-related functioning in their 
daily lives.
The main strength of our systematic scoping review 
is its comprehensive search strategy with 17 706 papers 
screened. However, there are also limitations. While 
most of the papers found reduced health-related func-
tioning among unwell pregnant or delivered women, 
this finding could be due to publication bias. As we only 
considered the published literature and did not review 
grey literature, we were unable to access the extent to 
which this was the case. Although we assessed quality of 
the studies based on definition of maternal morbidity 
and health-related functioning, inclusion of relevant 
controls, sampling methods and completeness of data, 
all publications relevant to our study aim in this scoping 
review were included. We relied on authors’ interpreta-
tions of their study results when the studies did not have 
a control or comparison group, or did not provide a 
statistical test comparing women’s functioning between 
morbid and non-morbid groups. Therefore, a bias may 
have been introduced in reporting impact of maternal 
morbidity on health-related functioning in the studies of 
poor quality. In addition, we may have overemphasised 
the degree to which existing tools document economic 
functions as some of the tools do not specifically address 
functioning at work, but rather asked about any difficulty 
in performing work or other regular daily activities to 
appreciate economic function (eg, SF-36 ‘During the 
past 4 weeks, have you had any of the following prob-
lems with your work or other regular daily activities as a 
result of any emotional problems?”). On the other hand, 
we may have underestimated the number of depres-
sion studies documenting maternal dysfunction as we 
excluded studies of mother–child interactions which did 
not explicitly address the functionality element. Lastly, 
while our qualitative approach fit well the objective of 
our scoping review, a quantitative meta-analysis of the 
findings to summarise the effects was not possible for 
any condition, as studies did not use the same analytical 
approach, tools, measures or timing of assessment for 
the different conditions under consideration.
concLusIon
While we found ample evidence that maternal morbidity 
impacts health-related functioning, the available literature 
does not appear to be sufficiently comprehensive because 
not all relevant functioning domains are studied and not 
all complications are studied to the same extent. The 
development of a scale specifically for maternal health, to 
be used alongside expansion of existing generic or condi-
tion-specific scales, such as WHODAS 2.0, would greatly 
advance our understanding of the burden of ill health 
associated with maternal morbidity and facilitate priority 
setting in maternal health, particularly with respect to its 
global dimension.
In the transition from the MDG to the Sustainable 
Development Goal framework, tremendous attention is 
rightfully being placed upon the need to understand the 
entire context of maternal health. As countries reduce 
maternal mortality and improve overall health systems, 
referred as the ‘obstetric transition,’ a proportion of 
maternal morbidity events increases.72 The UN Secre-
tary General’s Strategy for Women’s, Children’s, and 
Adolescent Health, and initiatives such as the EPMM 
consultations focus direct attention on this phenomenon 
and call for a holistic approach to improve the health and 
well-being of women, children and adolescents.5 73 The 
objective is to ensure that all ‘survive, thrive, and trans-
form.’ With regard to maternal health, it is critical to 
holistically understand the socioeconomic and environ-
mental determinants that contribute to pregnancy and 
the spectrum of maternal health-related functioning. To 
achieve this, we suggest the use of a frequently applied 
generic tool such as SF-36 and WHODAS 2.0 when 
comparability with other studies is needed. We also call 
for more research on the effects of direct complication 
on health-related functioning.
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